Stepping on the scale

How 10x Genomics is unlocking the genome

By giving other companies' short-read sequencers the ability to perform long reads, 10x Genomics Inc. expects researchers will be able to fully unlock the genome.

Co-founders CEO Serge Saxonov, COO and CTO Kevin Ness and President and CSO Ben Hindson previously worked together at genetic analysis company QuantaLife Inc., which was acquired by Bio-Rad Laboratories Inc. for $162 million plus milestones in 2011.

As the trio was thinking about what to do next in the genomics space, they observed that sequencing was getting dramatically faster and cheaper, but there still existed many areas of the genome that

Read the full 991 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE